erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
president trump tweeted monday that she “is doing really well” and would be leaving the hospital in “2 or 3 days” after her procedure.
.
it's the first successful medical treatment of a human fetus for the underlying cause of a genetic disorder, experts say
.
.
.
.
.
.
.
. the software can help physicians administer emergency treatment more quickly and also predict the one's chances of developing dementia.
.
.
.
.